SETH ANDERSON: Open Payments
NPI 1003290263 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 25 payments from 14 companies in 2025. Trend: 2023 $652 · 2024 $841 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $132 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| Verona Pharma, Inc. | 2 | $47 |
| Viatris Specialty LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| United Therapeutics Corporation | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: DUPIXENT, ZERBAXA, Ohtuvayre, YUPELRI, GLASSIA, OFEV, Tyvaso, BREZTRI.
Industry payments across NC — which companies pay providers there.
